July 2026
All columns and Brief analyses.
10 results
It's the Margin, Not the Print: Which Rally Has Real Fuel?
Super Micro rallied 15% and Capital One beat. The level is technical; the reason is economic: which move is carried by margin, which by a passing line item?
Measure, don't pledge: a rising sea and a flower falling behind
One model counts the flood risk on Britain's coasts; one experiment measures a wildflower falling behind. Both say the same thing: keep the measurement, not the pledge.
Policy Tunes the Rate, the Market Charges the Rest: The Equation Linking Yen and Bond
The yen slid past ¥163, and JGB yields are finally paying. Both are two ends of one equation: the price of money and whose balance sheet carries it.
Small lab, fast layer: Poolside and Google teach the same lesson from opposite ends
Poolside's 118-billion-parameter model routes only 8 billion per token, and Google keeps shipping its small Flash tier while the flagship waits — both point to value moving from the model to the routing layer around it.
The Capitals That Foot the Bill
Abuja is rescuing the kidnapped on its own roads; tankers bound for China and India are re-routing because of someone else's war. The quarrel of two capitals lands on the majority world's budget.
The Cargo That Turns to Suez, the Bill in the Senate
Two tankers made a U-turn in the Red Sea; a defense secretary read out a $37.5bn figure in the Senate. Both stories say the same thing: an embargo is not a wall but a detour — and every detour has an invoice.
The eye of partnership: the ocean's hidden table and a gaze two nations share
A camera on a whale shark's back shows us its table; two nations' shared satellite shows us the planet's hidden face. Both whisper the same thing: we are not alone.
The Field Does the Talking: Heat, Ethanol and the Smelter
Europe's heat wiped €2bn from the harvest, India blends fuel from the field, Washington rewards the smelter. Count the barrels and the tonnes; hear the story later.
The mouse rejoices, the human waits: a snail's venom and a mushroom's shadow
A snail's venom stops pain in mice; a mushroom changes 28 people's brains. In both, the real question is the same: in how many, and in whom?
The Narrative Ran to the IPO, the Model Stayed Private: Who Pays for the Mark?
Wall Street fees ran to $11.1 billion and IPOs to $104.8 billion, while Goldman routes the wealthy into direct private stakes. The pitch is lovely; now open the model.